Profile data is unavailable for this security.
About the company
Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, production and sales of chemical Active Pharmaceutical Ingredients (API) and intermediates. The Company mainly operates through two segments, including the New Drug and Intermediates Contract Development and Manufacturing Organization (CDMO) segment and the Specialty APIs and Intermediates segment. The New Drug and Intermediates CDMO segment mainly provides services for innovative medicines of pre-clinical chemical manufacturing and controls (CMC), clinical phases I, II and III, new drug application (NDA) and various stages after going public. The Specialty API and Intermediates segments mainly provides services including patent breakthroughs, production process improvement, drug certificate declaration, and cGMP standard commercial production for patented expired or soon-to-be-expired drugs for global chemical and generic drug manufacturers.
- Revenue in CNY (TTM)5.15bn
- Net income in CNY827.13m
- Incorporated1998
- Employees4.08k
- LocationZhejiang Jiuzhou Pharmaceutical Co LtdNo.99, Waisha Road, Jiaojiang DistrictTAIZHOU 318000ChinaCHN
- Phone+86 57 688706789
- Fax+86 57 688706788
- Websitehttp://www.jiuzhoupharma.com
More ▼
Mergers & acquisitions
| Acquired company | 603456:SHH since announced | Transaction value |
|---|---|---|
| Nanjing Kangchuanji Medicine Technology Co Ltd | -30.36% | 18.89m |
| Teva Pharmaceutical & Chemical (Hangzhou) Co Ltd | -26.83% | 34.00m |
Data delayed at least 15 minutes, as of Sep 30 2022 08:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fujian Kuncai Material Technology Co Ltd | 843.16m | 113.93m | 27.81bn | 729.00 | 244.07 | 15.72 | -- | 32.98 | 0.2435 | 0.2435 | 1.80 | 3.78 | 0.2762 | 0.9668 | 4.84 | 1,156,599.00 | 3.88 | 8.73 | 5.04 | 10.36 | 31.98 | 41.25 | 14.03 | 22.78 | 0.4425 | 6.85 | 0.4357 | 10.43 | 19.10 | 16.95 | -8.47 | 5.74 | 25.27 | -- |
| Hunan Changyuan Lico Co Ltd | 11.63bn | 1.14bn | 28.65bn | 1.50k | 17.47 | 4.05 | -- | 2.46 | 0.8499 | 0.8499 | 7.30 | 3.67 | 1.19 | 5.89 | 4.24 | 7,734,855.00 | 11.72 | -- | 20.96 | -- | 16.42 | -- | 9.85 | -- | 1.23 | -- | 0.2768 | -- | 240.25 | -- | 538.17 | -- | -- | -- |
| Suzhou Nanomicro Technology Co Ltd | 574.56m | 288.10m | 29.11bn | 536.00 | 93.61 | 20.85 | -- | 50.66 | 0.7713 | 0.7713 | 1.52 | 3.46 | 0.4109 | 0.819 | 4.97 | 1,071,937.00 | 20.74 | -- | 22.90 | -- | 82.22 | -- | 50.47 | -- | 4.09 | -- | 0.101 | -- | 117.74 | -- | 158.75 | -- | -- | -- |
| Sichuan Hebang Biotechnology Co Ltd | 13.43bn | 4.74bn | 29.14bn | 4.92k | 5.84 | 1.65 | -- | 2.17 | 0.5655 | 0.5655 | 1.60 | 2.00 | 0.7102 | 8.16 | 16.47 | 2,730,898.00 | 25.17 | 6.11 | 31.17 | 7.42 | 46.65 | 28.21 | 35.44 | 13.64 | 1.92 | 319.49 | 0.0777 | 18.55 | 87.56 | 23.30 | 7,284.28 | 56.91 | 20.69 | 26.95 |
| Zhejiang Longsheng Group Co., Ltd | 17.32bn | 2.27bn | 29.70bn | 7.80k | 13.04 | 0.9534 | -- | 1.71 | 0.7002 | 0.7002 | 5.33 | 9.58 | 0.2501 | 0.4446 | 5.60 | 2,220,434.00 | 3.87 | 7.87 | 6.93 | 11.64 | 29.37 | 39.79 | 15.47 | 23.24 | 0.5797 | 7.19 | 0.4239 | 21.16 | 6.76 | 6.16 | -19.21 | 10.71 | 8.65 | 4.56 |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.15bn | 827.13m | 30.18bn | 4.08k | 36.58 | 6.19 | -- | 5.86 | 0.9889 | 0.9889 | 6.16 | 5.85 | 0.7306 | 2.17 | 6.18 | 1,261,216.00 | 11.74 | 7.35 | 17.17 | 9.60 | 34.27 | 33.50 | 16.06 | 12.62 | 1.06 | -- | 0.204 | 50.01 | 53.48 | 19.70 | 66.56 | 41.57 | 31.86 | 35.09 |
| Meihua Holdings Group Co Ltd | 26.03bn | 3.92bn | 30.27bn | 12.95k | 7.88 | 2.57 | -- | 1.16 | 1.26 | 1.26 | 8.40 | 3.87 | 1.19 | 6.34 | 62.80 | 2,009,729.00 | 18.04 | 7.06 | 25.84 | 10.27 | 23.14 | 20.53 | 15.11 | 8.44 | 1.04 | -- | 0.3488 | 77.21 | 33.94 | 15.54 | 139.40 | 17.68 | 23.75 | 5.92 |
| Jiangsu Yangnong Chemical Co.,Ltd. | 14.72bn | 1.95bn | 30.99bn | 3.12k | 15.93 | 3.75 | -- | 2.10 | 6.28 | 6.28 | 47.51 | 26.68 | 1.02 | 6.72 | 4.52 | 4,722,367.00 | 13.52 | 11.02 | 24.19 | 19.79 | 25.48 | 26.03 | 13.21 | 12.07 | 1.16 | -- | 0.3206 | 20.31 | 20.45 | 32.23 | 1.02 | 22.71 | 18.85 | 8.61 |
| XTC New Energy Materials Xiamen Co Ltd | 23.30bn | 836.85m | 31.32bn | 1.97k | 31.32 | 6.33 | -- | 1.34 | 3.33 | 3.33 | 92.62 | 16.45 | 2.24 | 8.08 | 7.37 | 11,851,450.00 | 8.14 | -- | 19.01 | -- | 9.02 | -- | 3.64 | -- | 0.7931 | 8.96 | 0.5573 | -- | 94.82 | -- | 121.66 | -- | -- | -- |
| Skshu Paint Co Ltd | 11.45bn | -434.05m | 32.26bn | 10.34k | -- | 15.84 | -- | 2.82 | -1.16 | -1.16 | 30.49 | 5.41 | 0.9226 | 10.87 | 2.73 | 1,107,682.00 | -3.52 | 3.55 | -10.88 | 9.54 | 26.35 | 33.09 | -3.81 | 3.02 | 0.7346 | -5.16 | 0.7229 | 45.00 | 39.37 | 42.45 | -183.08 | -- | 63.86 | -- |
Data as of Sep 30 2022. Currency figures normalised to Zhejiang Jiuzhou Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
22.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2021 | 55.72m | 6.71% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2021 | 44.20m | 5.32% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2021 | 29.50m | 3.55% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2021 | 12.27m | 1.48% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2021 | 9.22m | 1.11% |
| China Fund Management Co., Ltd.as of 31 Dec 2021 | 9.22m | 1.11% |
| GF Fund Management Co., Ltd.as of 31 Dec 2021 | 8.59m | 1.04% |
| AXA-SPDB Investment Managers Co., Ltd.as of 31 Dec 2021 | 7.48m | 0.90% |
| Harvest Fund Management Co., Ltd.as of 31 Mar 2021 | 7.14m | 0.86% |
| Changjiang Pension Insurance Co. Ltd.as of 09 Aug 2021 | 6.75m | 0.81% |
More ▼
Data from 31 Dec 2021 - 30 Jun 2022Source: FactSet Research Systems Inc.
